Reboxetine - sold as Edronax by Pfizer - is no more effective at countering major depression than a placebo. Researchers from the German Institute for Quality and Efficiency in Health Care reviewed trials of the drug and found that the risk of taking
Read More...
Read the complete post at http://mentalhealthupdate.blogspot.com/2010/10/new-research-claims-reboxetine-is.html
Posted
Oct 15 2010, 02:29 AM
by
Mental Health Update